• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

  • There's just no denying
    good chemistry

    Explore the PRA HEALTH SCIENCES interactive experience to find out what makes us tick.

Social Media

See the latest interactions from our social media


Catch our team at the PhUSE Annual Conference 2014 on #DataTransparency. We'll be exhibiting and have...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences Files for Initial Public Offering

08 September 2014, Raleigh, N.C. PRA Health Sciences, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC)...

PRA Health Sciences Expands in Pennsylvania

26 August 2014, Blue Bell, PA – Blue Bell, Pennsylvania will soon be home to PRA Health Sciences’ largest office worldwide. PRA, a leading global Contract Research Organization (CRO), is...

PRA Advances to Become PRA Health Sciences

16 June 2014, RALEIGH, NC – PRA, a leading clinical research organization, today announced that it has changed its name to PRA Health Sciences (PRA). The name change to PRA Health Sciences...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

WHITEPAPER: Sponsor & CRO Pharmacovigilance Alliances
October 31, 2014

Outsourcing pharmacovigilance activities is a standard business practice in a rapidly expanding market segment. Irrespective of the required type of support, the outcome will be a positive experience if the guidances outlined in this whitepaper are followed.

Whitpaper - Global Biosimilar Development
October 28, 2014

Many different terms are used in different parts of the world to describe “biosimilar products.” It is important to understand and differentiate true biosimilars from others because of the potential concern for patient safety and efficacy.

We Are Dedicated To Minimizing Risk And Protecting Patient Safety
October 1, 2014

Pharmacovigilance solutions for the entire product lifecycle

The Fight Against Alzheimer’s Disease
September 8, 2014

US prevalence of Alzheimer’s Disease is currently at 5 million sufferers and is set to triple by 2050.


Find out what's happening next on PRA's event schedule

November 2 - November 6

Plan now for the meeting that extends your boundaries. Widen your personal network with scientists from all fields related to pharmaceutical sciences. Explore programming including Hot Topics covering both large and small pharma. Find the latest advances with more than 2,500 contributed papers. Find your supplier solutions in San Diego.

November 5 - November 6

Partnerships in Clinical Trials looks at the outsourcing relationship between pharma and biotech sponsors and providers in clinical trials. Since 2001, we have brought together creators, innovators, storytellers and rising stars to provoke change and demand solutions to the challenge of advancing clinical trial collaborations. Speaker: Kent Thoelke (Executive Vice President, Scientific and Medical Affairs, […]

November 5 - November 6

The Annual Pain & Migraine Therapeutics Summit is the US’s premier pain conference covering the field of pain research and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit […]

Read More >